Seeing Is Believing
Currently out of the existing stock ratings of Corinne Jenkins, 42 are a BUY (55.26%), 23 are a HOLD (30.26%), 11 are a SELL (14.47%).
Analyst Corinne Jenkins works at GOLDMAN SACHS with a stock forecast success ratio of 57.3% fulfilled within 142.61 days on average.
Corinne Jenkins’s has documented 148 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ITCI, Intracellular Th at 17-Apr-2024.
Analyst best performing recommendations are on AMAM (AMBRX BIOPHARMA . AMERICAN DEPOSITARY SHARES).
The best stock recommendation documented was for AMAM (AMBRX BIOPHARMA . AMERICAN DEPOSITARY SHARES) at 9/13/2023. The price target of $10 was fulfilled within 1 day with a profit of $1.16 (10.39%) receiving and performance score of 103.94.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
17.5
$-0.66 (-3.63%)
1 months 27 days ago
1/1 (100%)
$-3.09 (-15.01%)
44
Hold
1 years 10 months ago
8/9 (88.89%)
$-26.36 (-56.86%)
453
Hold
10
$-17.85 (-64.09%)
7
1 years 10 months ago
1/2 (50%)
$0.43 (7.40%)
15
Sell
8
$-19.85 (-71.27%)
16
1 years 10 months 16 days ago
2/2 (100%)
$0.9 (8.53%)
132
Hold
1 years 11 months ago
2/2 (100%)
$22.35 (98.68%)
1555
Which stock is Corinne Jenkins is most bullish on?
Which stock is Corinne Jenkins is most reserved on?
What Year was the first public recommendation made by Corinne Jenkins?